Jay A. Fishman Ltd’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,621
Closed -$826K 93
2017
Q3
$826K Buy
10,621
+50
+0.5% +$4.15K 0.17% 59
2017
Q2
$938K Sell
10,571
-220
-2% -$18.6K 0.2% 50
2017
Q1
$869K Sell
10,791
-243
-2% -$19K 0.2% 52
2016
Q4
$786K Buy
11,034
+200
+2% +$15.7K 0.19% 57
2016
Q3
$936K Sell
10,834
-13
-0.1% -$1.13K 0.23% 51
2016
Q2
$941K Hold
10,847
0.24% 53
2016
Q1
$814K Hold
10,847
0.21% 57
2015
Q4
$834K Sell
10,847
-169
-2% -$12.7K 0.2% 55
2015
Q3
$737K Hold
11,016
0.18% 60
2015
Q2
$816K Hold
11,016
0.17% 59
2015
Q1
$859K Buy
+11,016
New +$835K 0.18% 62

Other funds holding MDT

Jay A. Fishman Ltd's MDT Position: Q4 2017 in Review

Jay A. Fishman Ltd sold out of Medtronic (MDT) in Q4 2017, closing a stake of 10,621 shares — an estimated $826K sold.

Jay A. Fishman Ltd first reported a position in MDT in Q1 2015 and held it in 11 quarters. The position peaked at $941K in Q2 2016. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • Jay A. Fishman Ltd reported no remaining Medtronic position as of Q4 2017 after selling out during the quarter.
  • Jay A. Fishman Ltd sold 10,621 Medtronic shares in Q4 2017, an estimated $826K.
  • Jay A. Fishman Ltd first reported a position in Medtronic in Q1 2015 and held it in 11 quarters.
  • Jay A. Fishman Ltd's Medtronic position peaked at $941K in Q2 2016.
  • 1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Jay A. Fishman Ltd's 13F filing for Q4 2017, filed 5 Feb 2018.